[The CRUSADE study, evaluation model of quality in percutaneous coronary intervention]

M Ruiz Bailén1, L Rucabado Aguilar, E Aguayo de Hoyos

  • 1Unidad de Medicina Intensiva, Servicio de Cuidados Críticos y Urgencias, Hospital Universitario Médico Quirúrgico, Complejo Hospitalario de Jaén, Jaén, España. mrb1604@terra.es

Medicina Intensiva
|September 5, 2006
PubMed

Insights

Early invasive treatment for non-ST segment elevation acute coronary syndrome (NSTE-ACS) reduces mortality. However, this effective strategy is underutilized, primarily benefiting lower-risk patients.

Area of Science:

  • Cardiology
  • Clinical Research
  • Health Services Research

Context:

  • Clinical trial evidence and treatment guidelines do not guarantee optimal patient outcomes.
  • Real-world population studies are essential for evaluating care quality and treatment effectiveness.
  • Clinical registries provide valuable data for assessing adherence to guidelines and real-world outcomes.

Purpose:

  • To evaluate the utilization, prognosis, and predictive factors of an early invasive strategy using percutaneous coronary intervention (PCI) in high-risk patients with non-ST segment elevation acute coronary syndrome (NSTE-ACS).
  • To compare the effectiveness of early invasive strategy versus medical treatment in a large patient cohort.
  • To identify patient characteristics associated with the selection for early invasive treatment.

Summary:

  • The CRUSADE study analyzed 17,926 patients with NSTE-ACS, finding that 44.8% received cardiac catheterization within 48 hours.
  • Intrahospital mortality was significantly lower with the early invasive strategy (2.5%) compared to medical treatment (3.7%).
  • Patients undergoing early PCI were a selected group, with factors like cardiology care, younger age, and absence of renal or heart failure predicting its use.

Impact:

  • Despite demonstrating reduced mortality, the early invasive strategy for NSTE-ACS is not widely applied.
  • The benefits of early PCI are primarily observed in selected subgroups with lower comorbidity and those under cardiology care.
  • This highlights a gap between evidence-based recommendations and real-world clinical practice for acute coronary syndromes.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...